Therefore, we performed RNA-Seq analysis on paired patient samples from our index case to compare in descriptive terms baseline MYC wild-type tumor sample, with acquired MYC amplification at the time of distant metastatic disease while receiving anti-PD-1 therapy. Here, MYC is linked to metastatic neoplasm.